Latest Partnerships News

MyEco Group has trimmed its net loss by 8.1% in FY26, driven by a strategic shift toward higher-margin sustainable consumer products and operational cost savings. Australian retail sales surged 22.7%, underpinning a stronger revenue mix and improved cash flow.

Lindian Resources has secured exclusive rights to over 13,000 tonnes of heavy rare earth feedstock in Kazakhstan, aiming to boost output at its wholly owned SARECO processing facility with dysprosium, terbium, and yttrium-rich material.

Volt Group’s HY26 results showcase a surge in revenue and cashflow, powered by the 4D Delta acquisition and strong performances across its subsidiaries.

BluGlass Limited reported a 5% reduction in its net loss to A$10.39 million for FY26 despite a 10% revenue dip, boosted by new US defence and industry contracts and a significant capital raise to fund growth.

Mont Royal Resources has partnered with Alta Resource Technologies to investigate a novel protein-based method for producing high-purity rare earth oxides from the Ashram Project, aiming to deepen its processing capabilities within North America’s critical minerals supply chain.

Encounter Resources has appointed Simon Hay as Non-Executive Chairman and promoted Will Robinson to Managing Director/CEO, aligning leadership with its expanding niobium and copper-gold projects. The company’s Aileron niobium resource surged 54% in 2026, underpinning development ambitions.

Blue Star Helium has secured an extension of its helium offtake agreement at the Pinon Canyon Plant through March 2027, ensuring steady revenue while negotiating longer-term contracts.

Way2VAT Ltd surged revenue by 61% to A$4 million in H1 FY26, driven by client growth and its new AI e-invoicing platform. However, losses widened sharply, prompting cost cuts and debt facility extensions to sustain operations.

Liontown Limited (ASX:LTR) has reported its maiden profit and strong cash flow in FY26, completing its transition to fully underground mining at Kathleen Valley and advancing expansion plans with a final investment decision due early FY27.

Nexsen Limited (ASX:NXN) reported a 30% rise in net loss to $6.55 million for FY26, driven by ongoing investment in its Group B Streptococcus rapid diagnostic and Asia-Pacific growth initiatives following its October 2025 IPO.

The Agency Group Australia Ltd (ASX:AU1) reported a 21% jump in Gross Commission Income to $151.6 million for FY26, alongside a 56% reduction in net loss. The company expanded its agent network and property management portfolio, navigating a softening housing market with operational discipline.

Singular Health Group lifted revenues over fivefold to $1.43 million in FY26, driven by US commercial rollouts of its 3DICOM platform, but posted a $6.34 million loss. The company strengthened its US foothold with FDA clearance and a controlling stake in an associate.